A randomized trial of pegylated-interferon-alpha2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples